OOIR: Observatory of International Research

Papers

(The TQCC of European Heart Journal-Quality of Care and Clinical Outcomes is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Ambulance drive-thru troponin, ready to go?	94
Letter to the editor in response to Kobo et al. 2022	75
Implementing rapid algorithms for high-sensitivity troponin—economic benefits and caveat emptor	72
Evolving perspectives in personalized cardiovascular care	65
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease	53
Association of lipoprotein(a) level and major adverse cardiovascular events in adult cancer survivors with atherosclerotic disease	49
Secundum atrial septal defect closure in adults in the UK	40
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events	36
Applicability of guideline-informing lipid-lowering clinical trials to contemporary real-world patients with atherosclerotic cardiovascular disease	34
Beyond biomarkers: the relevance of supporting evidence in the diagnosis of periprocedural myocardial infarction	34
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis	33
Beyond weight loss in hypertrophic cardiomyopathy: metabolic therapy and the evolving treatment paradigm	33
Heart failure with reduced ejection fraction: a systematic review of clinical practice guidelines and recommendations	29
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings	29
Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations	29
Beyond the SMuRF-less paradox: disaggregation may restore clinical meaning	27
Intracoronary imaging for percutaneous coronary intervention: worth the cost?	26
Alcoholic cardiomyopathy-attributed mortality in Europe, 2012–20	26
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes	25
Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings	24
Lower STEMI mortality at high volume tertiary centre: Insights from a compact multi-centre region	24
Correction to: Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry	23
Mitral valve prolapse: incidence and prognosis related to serum levels of sex hormone-binding globulin	22
Fifteen-year secular changes in the care and outcomes of patients with out-of-hospital cardiac arrest in Japan: a nationwide, population-based study	22
Mapping the modern heart failure epidemic: growing burden, root causes, and widening inequalities	22

The rising burden of enterococcal endocarditis: insights from contemporary European data	21
Mental disorders, mortality following myocardial infarction, and the impact of the COVID-19 pandemic in England: a cohort study	21
Correction to: Trends in risk factors among young patients with acute myocardial infarction: a nationwide cohort study	21
Influence of multiple risk factor control level on cardiovascular outcomes in hypertensive patients	21
Correction to: Optimizing patient triage on the waiting list for transcatheter aortic valve replacement: the clinical utility of the cardiac damage staging system	20
From pyramid to temple: evolution of heart failure therapy in the new Renaissance	20
Cost-effectiveness of population screening for aortic stenosis	20
Association between delayed statin initiation after high LDL-cholesterol detection and cardiovascular risk in general health screening examinees	20
Erratum to: Economic burden of patients living with heart disease in the last years of life in Australia: a retrospective analysis using linked data	19
Impact of system efficiency on out-of-hospital cardiac arrest outcomes and hospital stay: an observational study from Lombardia CARe	19
Economic burden of cardiovascular disease in the United Kingdom	19
Cost-effectiveness of atrial fibrillation screening programmes across European nations	18
Association of cumulative health status with subsequent mortality in patients with acute heart failure	18
Heart failure with preserved ejection fraction management: a systematic review of clinical practice guidelines and recommendations	18
Sex-based differences in heart failure development during STEMI hospitalization	17
Prognostic impact of anaemia in patients undergoing aortic valve replacement: a nationwide study	17
Rapid Assessment and Treatment In Decompensated Aortic Stenosis (ASTRID-AS study)- A pilot study	17
Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort	17
The beginning of wisdom is the definition of terms: counting heart failure hospitalizations	17
Impact of low physical activity on cardiovascular disease across regions and demographic groups: insights from the Global Burden of Disease Study	16
Standardized and hierarchically classified heart failure and complementary disease monitoring outcome measures: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)	16
Advanced maternal age at first delivery as a risk factor for long-term cardiovascular disease	16
Greenness exposure and mortality risk in a cardio-oncologic population	16
Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–22	16
The semaglutide paradox in non-overweight diabetes: a benefit without explanation	15
Machine learning for prediction of all-cause mortality after transcatheter aortic valve implantation	15
Contemporary trends in incident ischaemic stroke, intracranial haemorrhage, and mortality in individuals with atrial fibrillation	15
Risk-standardized mortality metric to monitor hospital performance for chest pain presentations	15
LDL-cholesterol lowering, the earlier the better: lessons from the real world	15
Periprocedural myocardial infarction after coronary artery bypass grafting: defining what matters	15
Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort study	15
Cancer and the risk of perioperative arterial ischaemic events	15
Multi-domain biomarkers for holistic care of cancer survivors	14
Predictive and prognostic value of different cardiac troponin assays: a nationwide register-based cohort study	14
Hospital admissions in the last year of life of patients with heart failure	13
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly	13
Transcatheter vs. surgical mitral valve interventions in patients with prior coronary artery bypass grafting	13
Current prevalence and remaining challenges of sodium-glucose cotransporter 2 inhibitors in patients with heart failure	13
Ultrasound evaluation of placental volume and placental vascular indices in women developing hypertensive disorders in pregnancy compared to controls: a systematic review and meta-analysis	13
First clinical experience with the Transthyretin Amyloidosis-Quality of Life questionnaire (ATTR-QoL): associations with clinical characteristics and established patient-reported outcomes	13
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry	13
Clinical Outcomes in Hospitalized Patients with Cancer and New versus Preexistent Atrial Fibrillation	13
Addressing the impact of social determinants of health in congenital heart disease	12
Large-scale AI analysis reveals missed opportunities in albuminuria testing and disease-modifying therapy implementation	12
Quality of life and societal costs in patients with dilated cardiomyopathy	12
Cost-effectiveness of the ABCStroke pathway in ischaemic stroke care: a UK pilot analysis	12
Treating the patient, not just the valve: can we predict which transcatheter aortic valve implantation patients truly benefit?	12
A decade of follow-up: atrial fibrillation, pulmonary pressure, and the progression of tricuspid regurgitation	12
Integrating cardiac biomarkers into the AHA PREVENT equations: impact on atherosclerotic cardiovascular disease risk stratification	11
Bacteraemia and infective endocarditis following left-sided heart valve surgery	11

Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries	11
Suspected Non-ST-elevation acute coronary syndrome meeting rapid rule-out criteria: resource utilization, diagnostic yield, and clinical outcomes of hospital admission	11
POAF after CABG: early risk, landmark bias, and the case for selective anticoagulation	11
RNA-targeted therapeutics in arterial hypertension	11
Validating national registry data for randomized trials: comparison of registry-derived cardiovascular events with and without adjudication in the BETAMI-DANBLOCK trial	11
More from less: the case of non-invasive imaging in angina with non-obstructive coronary artery disease	10
Trends and projections of heart failure among adolescents and young adults: an in-depth analysis for the Global Burden of Disease Study 2021	10
Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	10
Utility of patient-reported perception of symptom change in patients with acute decompensated heart failure in predicting post-discharge clinical outcomes: insights from KCHF registry	10
National health expenditure per capita is associated with CRT implantation practice: findings from the ESC CRT Survey II with 11 088 patients	10
Validated 1-Year Mortality Prediction in Patients with Three-Vessel Disease Undergoing Contemporary PCI: Insights from the Multivessel TALENT trial	10
Beta-blockers in patients with uncomplicated arterial hypertension: data from the Campania Salute Network Registry	10
Clinical outcomes following invasive cardiovascular interventions in frail populations: a systematic review and meta-analysis	10
Ischaemic cerebrovascular events post-atrial fibrillation catheter ablation: a descriptive report on the ITHACA database	9
Evaluation of a combined symptom-based questionnaire and capillary natriuretic peptides testing for early detection of heart failure: a Heart Failure Awareness Days nationwide screening study (DEPIC F	9
Non-invasive physiological assessment of intermediate coronary stenoses from plain angiography through artificial intelligence: the STARFLOW system	9
The less lonely and the more satisfied you are, the merrier is … the heart!	9
Association of baseline and changes in health-related quality of life with mortality following myocardial infarction: multicentre longitudinal linked cohort study	9
Current epidemiology and management of acute heart failure: the multicenter prospective OFICA2 cohort	9
Severe LVOT obstruction in HCM: effects on exercise capacity and outcomes from cardiopulmonary exercise testing combined with stress echocardiography	9
Elementary school performance of children with congenital heart disease: a Danish nationwide cohort study	9
Implantable cardioverter defibrillators in heart failure with reduced ejection fraction after myocardial infarction: the need for contemporary evidence	9
Method validation of cardiopulmonary exercise testing: intra- and inter-device comparisons across four metabolic carts	9
Global, regional, and national burden of atrial fibrillation/flutter related to metabolic risks over three decades: estimates from the global burden of disease study 2019	9
Editorial: impact of catheter-directed thrombolysis on the socioeconomic burden of pulmonary embolism in Germany a cost-effectiveness analysis: who dares wins	9
Incidence, predictors, and prognostic impact of rehospitalization after transcatheter aortic valve implantation	9
Risk charts are not neutral: reconsidering threshold effects in SCORE2-based treatment eligibility	9
Optimizing anticoagulant therapy: is pharmacist-led intervention the best	8
Trends and risk factors analysis of aortic aneurysm mortality in China over thirty years: based on the global burden of disease 2019 data	8
Reperfusion strategies on the clinical outcomes of ST-elevation myocardial infarction patients over 80 years old in China	8
Impact of COVID-19 pandemic on the incidence and prevalence of postural orthostatic tachycardia syndrome	8
Predictive factors of surgical repair technique in infants with coarctation of the aorta	8
Renin–angiotensin system inhibition and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: findings from CCC-ACS project and a nationwide electronic health reco	8
Quality of care and long-term survival after ST-elevation myocardial infarction in adults with cancer	8
Has the first year of the COVID-19 pandemic reversed the trends in CV mortality between 1999 and 2019 in the United States?	8
Atrial fibrillation ablation in hypertrophic obstructive cardiomyopathy: are we there yet?	8
Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–2019	8
Heart failure in an ageing world: closing the evidence-equity gap	8
Disparities in ST-elevation myocardial infarction diagnosis and management among patients with mental health conditions	7
Trends in atrial fibrillation-related mortality in Europe, 2008–2019	7
Comprehensive risk factor management for hypertensive patients	7
Association of atrial fibrillation with survival in patients with low-flow low-gradient aortic stenosis with preserved ejection fraction undergoing TAVI	7
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings	7
Real-world evidence and quality improvement in heart failure and cardiomyopathies	7
Temporal trends in loss of expected lifetime associated with cardiovascular complications following newly diagnosed atrial fibrillation: a Danish nationwide cohort study from 2000 to 2022	7
Measuring what matters in out-of-hospital cardiac arrest care	7
Diagnostic accuracy, clinical characteristics, and prognostic differences of patients with acute myocarditis according to inclusion criteria	7
Adapting predictive risk models and preventive strategies across different socio-economic regions to reduce global cardiovascular burden	7
One year healthcare consumption prior to sudden cardiac death	7
First systematic screening of cardiac amyloidosis in the elderly: findings and cost-effectiveness profile	7
Cohort profile: the prospective cohort study on the incidence of metabolic diseases and risk factors in Shunde, China (Speed-Shunde cohort)	7
Clearing cardiac patients for take-off: is the evidence fit to fly?	7
Current management of transition and multidisciplinary care of patients with inherited and rare cardiomyopathies in Europe: results of the European Reference Network for rare and low prevalence comple	7
Tricuspid transcatheter edge-to-edge repair for tricuspid valve regurgitation: a sex-based real-world analysis from the TRI-SPA registry	7
Comment on ‘association of menopausal hormone therapy with incident cardiovascular disease in women veterans’	7
Italy passes obesity law: an opportunity to prevent cardiovascular disease across Europe	7
Regional disparities in heart transplant mortality in the USA	6
Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study	6
Rigour of development of European Society of Cardiology, American College of Cardiology and American Heart Association guidelines over a 12-year period (2013–2024): a systematic review of guidelines	6
Impact of intravascular ultrasound for coronary bifurcations treated with last-generation stents: insights from the ULTRA-BIFURCAT registry	6
Assessing the health impact of low seafood omega-3 intake on ischaemic heart disease: trends, demographic disparities, and forecasts	6
Response to the correspondence ‘from composite events to clinical action: disentangling arrhythmia risk in a new Fabry CMR prognostic score’	6
The burden of atrial fibrillation related to metabolic risks: different countries and territories, yet the same challenges	6
Inequality across the cardiac rehabilitation trajectory in Denmark: investigating key sociodemographic and health-related drivers	6
Mind the missed-fibrinolysis gap	6
Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study	6
Relationship between hospital mortality and readmission rates after transcatheter aortic valve replacement	6
Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence	6